retatrutide lawsuit Company linked to raid on illicit weight-loss drug facility still selling unlicensed drugs | Consumer affairs Biologics Archives - Drug Discovery

As we achieve greater weight loss with any GLP-1 medicine, greater adverse events are common

We respond with tailored court motions and protective orders to keep discovery moving a detail that can shorten case time by months and preserve leverage when settlement discussions begin

This dosage can be increased to 1.5 mg once weekly if necessary

These outcomes lead to the remodeling of the extracellular matrix, oxidative stress, inflammation, cardiomyocyte apoptosis, fibrosis, and metabolic abnormalities [55]

There is now a key new cancer prevention research question, whether this drug class might significantly reduce cancer risk with long-term use